Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy

Neurobiology of Disease

Volumn 47, Issue 3, 2012, Pages 331-337

  Perez, Edgar L ^a   Lauritzen, Fredrik ^a,b   Wang, Yue ^a   Lee, Tih Shih W ^a   Kang, Dewey ^a   Zaveri, Hitten P ^a   Chaudhry, Farrukh A ^b,c   Ottersen, Ole P ^b   Bergersen, Linda H ^b   Eid, Tore ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Animal models; Excitotoxicity; Glutamine synthetase; Hippocampal sclerosis; Methionine sulfoximine

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; METHIONINE SULFOXIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVITY; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOGOLD ELECTRON MICROSCOPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; SEIZURE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ASTROCYTES; BRAIN WAVES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; GLUTAMIC ACID; HIPPOCAMPUS; MALE; METHIONINE SULFOXIMINE; MICROSCOPY, IMMUNOELECTRON; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862207260     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.05.010     Document Type: Article

References (51)

1. Amatniek J.C., et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006, 47:867-872.
2. Amiry-Moghaddam M., Ottersen O.P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003, 4:991-1001.
3. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
4. Araque A., et al. SNARE protein-dependent glutamate release from astrocytes. J. Neurosci. 2000, 20:666-673.
5. Basarsky T.A., et al. Glutamate release through volume-activated channels during spreading depression. J. Neurosci. 1999, 19:6439-6445.
6. Bertram E.H., et al. Design and construction of a long-term continuous video-EEG monitoring unit for simultaneous recording of multiple small animals. Brain Res. Brain Res. Protoc. 1997, 1997:85-97.
7. Bezzi P., et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391:281-285.
8. Bidmon H.J., et al. Glutamine synthetase becomes nitrated and its activity is reduced during repetitive seizure activity in the pentylentetrazole model of epilepsy. Epilepsia 2008, 49:1733-1748.
9. Butterfield D.A., et al. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J. Neurochem. 1997, 68:2451-2457.
10. Cavus I., et al. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol. 2005, 57:226-235.
11. Chaudhry F.A., et al. The glutamine commute: take the N line and transfer to the A. J. Cell Biol. 2002, 157:349-355.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
13. Derouiche A., et al. Loss of layer-specific astrocytic glutamine synthetase immunoreactivity in slice cultures of hippocampus. Eur. J. Neurosci. 1993, 5:122-127.
14. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993, 341:1607-1610.
15. Eid T., et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 2004, 363:28-37.
16. Eid T., et al. Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1193-1198.
17. Eid T., et al. Increased expression of phosphate-activated glutaminase in hippocampal neurons in human mesial temporal lobe epilepsy. Acta Neuropathol. (Berl) 2007, 113:137-152.
18. Eid T., et al. Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats. Brain 2008, 131:2061-2070.
19. Fellin T., et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004, 43:729-743.
20. Gloor P. Mesial temporal sclerosis: historical background and an overview from a modern perspective. Epilepsy Surgery 1991, 689-703. Raven Press, New York. H. Luders (Ed.).
21. Haberle J., et al. Congenital glutamine deficiency with glutamine synthetase mutations. N. Engl. J. Med. 2005, 353:1926-1933.
22. Haberle J., et al. Inborn error of amino acid synthesis: human glutamine synthetase deficiency. J. Inherit. Metab. Dis. 2006, 29:352-358.
23. Hauser W.A., et al. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991, 32:429-445.
24. Hensley K., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 1995, 65:2146-2156.
25. Huang T.L., O'Banion M.K. Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes. J. Neurochem. 1998, 71:1436-1442.
26. Jackson M.J., et al. Effect of dibutyryl cyclic AMP and dexamethasone on glutamine synthetase gene expression in rat astrocytes in culture. Neurochem. Res. 1995, 20:201-207.
27. Jenstad M., et al. System A transporter SAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by glutamate. Cereb. Cortex 2009, 19:1092-1106.
28. Jourdain P., et al. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 2007, 10:331-339.
29. Kimelberg H.K., et al. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J. Neurosci. 1990, 10:1583-1591.
30. Laake J.H., et al. Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J. Neurochem. 1995, 65:871-881.
31. Lee T.S., et al. Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy. Acta Neuropathol. (Berl) 2004, 108:493-502.
32. Martinez-Hernandez A., et al. Glutamine synthetase: glial localization in brain. Science 1977, 195:1356-1358.
33. Nadler J., Cuthbertson G. Kainic acid neurotoxicity toward the hippocampal formation: dependence on specific excitatory pathways. Brain Res. 1980, 195:47-56.
34. Nadler J.V., et al. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 1978, 271:676-677.
35. Olney J.W. Neurotoxicity of excitatory amino acids. Kainic Acid as a Tool in Neurobiology 1978, 37-70. Raven Press, New York. E.G. McGeer (Ed.).
36. Olney J.W., et al. Glutamate-induced brain damage in infant primates. J. Neuropathol. Exp. Neurol. 1972, 31:464-488.
37. Olney J.W., et al. Excitotoxic mechanisms of epileptic brain damage. Advances in neurology 1986, 857-877. Raven Press, New York. A.V. Delgado-Escueta (Ed.).
38. Otis T.S., Jahr C.E. Anion currents and predicted glutamate flux through a neuronal glutamate transporter. J. Neurosci. 1998, 18:7099-7110.
39. Ottersen O.P. Postembedding light- and electron microscopic immunocytochemistry of amino acids: description of a new model system allowing identical conditions for specificity testing and tissue processing. Exp. Brain Res. 1987, 69:167-174.
40. Perez E., et al. Program No. 254.20. 2010 Neuroscience Meeting Planner 2010, San Diego, CA: Society for Neuroscience.
41. Peters A., et al. The fine structure of the nervous system. Neurons and their supporting cells 1991, Oxford University Press, New York.
42. Racine R.J., et al. Rates of motor seizure development in rats subjected to electrical brain stimulation: strain and inter-stimulation interval effects. Electroencephalogr. Clin. Neurophysiol. 1973, 35:553-556.
43. Smith C.D., et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10540-10543.
44. Stanimirovic D.B., et al. Developmental regulation of glutamate transporters and glutamine synthetase activity in astrocyte cultures differentiated in vitro. Int. J. Dev. Neurosci. 1999, 17:173-184.
45. Svenneby G. Pig brain glutaminase: purification and identification of different enzyme forms. J. Neurochem. 1970, 17:1591-1599.
46. Tian G.F., et al. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
47. Torp R., et al. Cellular and subcellular redistribution of glutamate-, glutamine- and taurine-like immunoreactivities during forebrain ischemia: a semiquantitative electron microscopic study in rat hippocampus. Neuroscience 1991, 41:433-447.
48. van der Hel W.S., et al. Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology 2005, 64:326-333.
49. Vardimon L., et al. Glucocorticoid control of glial gene expression. J. Neurobiol. 1999, 40:513-527.
50. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
51. Wang Y., et al. The development of recurrent seizures after continuous intrahippocampal infusion of methionine sulfoximine in rats: a video-intracranial electroencephalographic study. Exp. Neurol. 2009, 220:293-302.